✦ LIBER ✦

The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy

✍ Scribed by Xia Wu; Qin-Mei Feng; Ying Wang; Jun Shi; Hai-Liang Ge; Wen Di

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel and Carboplatin Combination C

✍ Minoru Watanabe; Yoichi Aoki; Masatoshi Tomita; Takaaki Sato; Yoshihiro Takaki; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Sorafenib in combination with carboplati

✍ Martin Pölcher; Meike Eckhardt; Christoph Coch; Matthias Wolfgarten; Kirsten Küb 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 203 KB

First-line chemotherapy with epidoxorubi

✍ A Romanini; L Tanganelli; F Carnino; A Fanucchi; R Lionetto; S Pastorino; S Cosi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Experience with single-agent paclitaxel

✍ John P. Micha; Bram H. Goldstein; Julie A. Mattison; Kathy Bader; Cheri Graham; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 85 KB

First-Line Chemotherapy with Weekly Pacl

✍ Jalid Sehouli; Dirk Stengel; Dirk Elling; Olaf Ortmann; Jens Blohmer; Hanno Ries 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Carboplatin hypersensitivity induced by

✍ Y. Watanabe; H. Nakai; H. Ueda; K. Nozaki; H. Hoshiai 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB